RUNX2 and ocular melanoma: By the end of day 21, Runx2 expression decreased slightly; nevertheless, the level in OM and HGOM-treated cells remained ~2-fold above the level determined at day 2 and significantly higher as compared to HG (p < 0.001 and p < 0.01, respectively) (Figure 2B).